BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 2015;26:23-9. [PMID: 25566699 DOI: 10.1016/j.ejim.2014.12.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Stine JG, Argo CK, Pelletier SJ, Maluf DG, Caldwell SH, Northup PG. Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World J Hepatol 2017; 9(3): 139-146 [PMID: 28217250 DOI: 10.4254/wjh.v9.i3.139] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
2 Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis. Int J Hepatol. 2018;2018:8432781. [PMID: 29973997 DOI: 10.1155/2018/8432781] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
3 Stine JG, Northup PG. Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems. Clin Liver Dis 2017;21:253-74. [PMID: 28364812 DOI: 10.1016/j.cld.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
4 Ghazaleh S, Beran A, Aburayyan K, Nehme C, Patel D, Khader Y, Sharma S, Aziz M, Abdel-Aziz Y, Hammad T, Nawras A. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:104-10. [PMID: 33414629 DOI: 10.20524/aog.2020.0544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mohan BP, Aravamudan VM, Khan SR, Ponnada S, Asokkumar R, Adler DG. Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: Systematic review and meta-analysis. Ann Gastroenterol 2020;33:521-7. [PMID: 32879600 DOI: 10.20524/aog.2020.0503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Qi X, Valla DC, Guo X. Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients. Gastroenterology 2018;154:760-1. [PMID: 29351830 DOI: 10.1053/j.gastro.2017.09.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, Beyer-Westendorf J, Sartori MT, Barillari G, Santoro R, Kamphuisen PW, Alatri A, Malato A, Vidili G, Oh D, Schulman S, Ageno W; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost 2021;19:983-91. [PMID: 33306241 DOI: 10.1111/jth.15214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:1187-93. [PMID: 30074506 DOI: 10.1097/MEG.0000000000001219] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 7.7] [Reference Citation Analysis]
9 Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal Vein Thrombosis: Diagnosis and Endovascular Management. Rofo 2021. [PMID: 34649289 DOI: 10.1055/a-1642-0990] [Reference Citation Analysis]
10 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Mancuso A. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Curr Hepatology Rep 2017;16:158-63. [DOI: 10.1007/s11901-017-0344-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Stine JG, Northup PG. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Dig Dis Sci 2019;64:619-26. [PMID: 30560339 DOI: 10.1007/s10620-018-5427-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
13 Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol. 2016;28:739-743. [PMID: 27075588 DOI: 10.1097/meg.0000000000000633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Riva N, Ageno W. Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. Vasc Med 2017;22:529-40. [PMID: 29202678 DOI: 10.1177/1358863X17734057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
15 Lim HQC, Lee XWJ, Mathias N. A Rare Finding of Falciform Ligament Thrombosis as a Sequel of Acute Pancreatitis. Case Rep Radiol 2017;2017:2879568. [PMID: 29403671 DOI: 10.1155/2017/2879568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Mazzarelli C, Vangeli M, Airoldi A. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis. Clinical Gastroenterology and Hepatology 2019;17:797-8. [DOI: 10.1016/j.cgh.2018.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Valeriani E, Di Nisio M, Riva N, Cohen O, Porreca E, Senzolo M, De Gottardi A, Magaz M, Garcia-Pagan JC, Ageno W. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Thromb Haemost 2021;121:867-76. [PMID: 33525037 DOI: 10.1055/s-0040-1722192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Summers KL, Davis KA, Nisly SA. Bleeding Risk of Therapeutic Unfractionated Heparin and Low Molecular Weight Heparin in Patients with Cirrhosis. Clin Drug Investig 2020;40:191-6. [PMID: 31755014 DOI: 10.1007/s40261-019-00875-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wang HL, Lu WJ, Zhang YL, Nie CH, Zhou TY, Zhou GH, Zhu TY, Wang BQ, Chen SQ, Yu ZN, Jing L, Sun JH. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study. Front Med (Lausanne) 2021;8:737984. [PMID: 34671621 DOI: 10.3389/fmed.2021.737984] [Reference Citation Analysis]
20 Northup PG MD, Davis JPE. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective. J Transl Int Med 2018;6:1-5. [PMID: 29607296 DOI: 10.2478/jtim-2018-0001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Kojima S, Watanabe N, Koizumi J, Kokubu S, Murashima N, Matsutani S, Obara K. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension: Current status of portal vein thrombosis in Japan. Hepatol Res 2018;48:244-54. [DOI: 10.1111/hepr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
22 Qi X, Han G, Ye C, Zhang Y, Dai J, Peng Y, Deng H, Li J, Hou F, Ning Z, Zhao J, Zhang X, Wang R, Guo X. Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Med Sci Monit 2016;22:2528-50. [PMID: 27432511 DOI: 10.12659/msm.898866] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
23 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gîrleanu I, Trifan A, Stanciu C, Sfarti C. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. World J Gastroenterol 2018; 24(39): 4419-4427 [PMID: 30356984 DOI: 10.3748/wjg.v24.i39.4419] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
25 Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3. [PMID: 30221012 DOI: 10.15761/JTS.1000182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
26 Verbeek TA, Stine JG, Saner FH, Bezinover D. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplant Direct 2018;4:e403. [PMID: 30534594 DOI: 10.1097/TXD.0000000000000843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
27 Nicoară-Farcău O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A, Barrufet M, Burrel M, Hernández-Gea V, García-Pagán JC. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:673-81. [PMID: 32820481 DOI: 10.1055/s-0040-1715473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Cui S, Fu Z, Feng Y, Xie X, Ma X, Liu T, Wang L, Wu H, Zhu Q. The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. Thromb Res 2018;161:7-11. [PMID: 29178991 DOI: 10.1016/j.thromres.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
29 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;153:480-487.e1. [PMID: 28479379 DOI: 10.1053/j.gastro.2017.04.042] [Cited by in Crossref: 162] [Cited by in F6Publishing: 124] [Article Influence: 32.4] [Reference Citation Analysis]
30 Qi X, De Stefano V, Guo X. Anticoagulation with intravenous unfractionated heparin and major bleeding in cirrhosis. Hepatology 2016;64:2269-70. [PMID: 27474891 DOI: 10.1002/hep.28743] [Reference Citation Analysis]
31 Sacco M, Tardugno M, Lancellotti S, Ferretti A, Ponziani FR, Riccardi L, Zocco MA, De Magistris A, Santopaolo F, Pompili M, De Cristofaro R. ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portavein thrombosis in compensated cirrhosis. A prospective observational study. Dig Liver Dis 2022:S1590-8658(22)00543-6. [PMID: 35778228 DOI: 10.1016/j.dld.2022.06.004] [Reference Citation Analysis]
32 Qi X, Dai J, Yang M, Ren W, Jia J, Guo X. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Gastroenterol Res Pract 2015;2015:480842. [PMID: 25810714 DOI: 10.1155/2015/480842] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
33 Gong C, Qin X, Yang J, Guo T. The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis. Gastroenterol Res Pract 2017;2017:9216172. [PMID: 28676822 DOI: 10.1155/2017/9216172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterol 2019;19:217. [PMID: 31842768 DOI: 10.1186/s12876-019-1140-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
35 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int 2016;36:667-76. [PMID: 26235541 DOI: 10.1111/liv.12929] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
37 Li Z, Xu WT, Xu XB, Qi XS. Heparins for prevention and treatment of venous thromboembolism in cirrhosis: Research advances. Shijie Huaren Xiaohua Zazhi 2022; 30(9): 381-386 [DOI: 10.11569/wcjd.v30.i9.381] [Reference Citation Analysis]
38 Proietti M, Marzona I, Vannini T, Colacioppo P, Tettamanti M, Foresta A, Fortino I, Merlino L, Lip GYH, Roncaglioni MC. Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. Eur Heart J Cardiovasc Pharmacother 2021;7:f84-92. [PMID: 32129845 DOI: 10.1093/ehjcvp/pvaa015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Zhang N, Yao Y, Xue W, Wu S. Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: A systematic review and meta-analysis. Biomed Rep 2016;5:483-90. [PMID: 27699018 DOI: 10.3892/br.2016.755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
40 Zhang L, Huan H, Tong H, Wei B, Wang Z, Liu C, Wu H. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study. Medicine (Baltimore) 2020;99:e18737. [PMID: 31914090 DOI: 10.1097/MD.0000000000018737] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Drolz A, Fuhrmann V. Reply. Hepatology 2016;64:2270-1. [PMID: 27482942 DOI: 10.1002/hep.28757] [Reference Citation Analysis]
42 Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z, Zhao Q, Qi X. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatol Int 2019;13:468-81. [PMID: 31175581 DOI: 10.1007/s12072-019-09951-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
43 Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, Baker T, Abecassis M, Caicedo JC, Ladner D, Fryer J, Riaz A, Lewandowski RJ, Salem R. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort. J Vasc Interv Radiol 2017; 28: 1714-1721. e2. [PMID: 29050854 DOI: 10.1016/j.jvir.2017.08.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
44 Ponthus S, Spahr L, Casini A, Berney T, Frossard J, Majno P, Elkrief L. Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study. European Journal of Gastroenterology & Hepatology 2020;32:395-400. [DOI: 10.1097/meg.0000000000001522] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
46 To UK, Garcia-Tsao G. PRO: Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation. Clin Liver Dis (Hoboken) 2018;12:74-9. [PMID: 30988915 DOI: 10.1002/cld.717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021;22:176-86. [PMID: 33470535 DOI: 10.1111/1751-2980.12970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Ilcewicz HN, Martello JL, Piechowski K. Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis. Eur J Gastroenterol Hepatol 2021;33:911-6. [PMID: 33079786 DOI: 10.1097/MEG.0000000000001958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
49 Nakayama S, Murashima N. Acute Portal Vein Thrombosis Treated with Recombinant Human Soluble Thrombomodulin Combined with Antithrombin III. Case Rep Med 2020;2020:8268016. [PMID: 32328109 DOI: 10.1155/2020/8268016] [Reference Citation Analysis]
50 Bergère M, Erard-poinsot D, Boillot O, Valette P, Guillaud O, Chambon-augoyard C, Dumortier J. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe. Clinics and Research in Hepatology and Gastroenterology 2019;43:395-402. [DOI: 10.1016/j.clinre.2018.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
51 Williams C, Stewart E, Conzen KD, Wolf S, Tran TT. Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation. Semin Cardiothorac Vasc Anesth 2021;25:200-7. [DOI: 10.1177/1089253220982183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.05.032] [Reference Citation Analysis]
53 Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. Am J Gastroenterol 2021;116:1447-64. [PMID: 33630766 DOI: 10.14309/ajg.0000000000001194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
54 Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:82-89. [PMID: 26513611 DOI: 10.1097/meg.0000000000000482] [Cited by in Crossref: 71] [Cited by in F6Publishing: 34] [Article Influence: 11.8] [Reference Citation Analysis]
55 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Reference Citation Analysis]
56 Ng CH, Tan DJH, Nistala KRY, Syn N, Xiao J, Tan EXX, Woo FZ, Chew NWS, Huang DQ, Dan YY, Sanyal AJ, Muthiah MD. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis. Hepatol Int 2021;15:1196-206. [PMID: 34417718 DOI: 10.1007/s12072-021-10247-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Li J, Qi X, Deng H, Peng Y, Shao L, Ma J, Sun X, Li H, Guo X. Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Gastroenterol Rep (Oxf) 2016;4:315-9. [PMID: 26672007 DOI: 10.1093/gastro/gov059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
58 Liew A, Douketis J. Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Intern Emerg Med 2016;11:1037-40. [PMID: 27216797 DOI: 10.1007/s11739-016-1463-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Zhang L, Hu B, Li W, Huang P, Zhang S, Zhong BY, Ni CF. 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. Cardiovasc Intervent Radiol 2020;43:196-203. [PMID: 31602496 DOI: 10.1007/s00270-019-02346-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Dong S, Qi H, Li Y, Men P, Alifu M, Zhang Y, Li Y, Zhao R. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat? Hepatol Int 2021. [PMID: 34487316 DOI: 10.1007/s12072-021-10233-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Lin W, Lu X, Fan F, Hu Y. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies. CURR MED SCI 2018;38:575-81. [DOI: 10.1007/s11596-018-1916-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
62 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 26.3] [Reference Citation Analysis]
63 Tang W, Wang Y, Zhao X, Wang X, Zhang T, Ou X, Shou W, You H, Jia J. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis. Eur J Gastroenterol Hepatol. 2015;27:672-678. [PMID: 25923942 DOI: 10.1097/meg.0000000000000352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
64 Stine JG, Argo CK, Pelletier SJ, Maluf DG, Northup PG. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int 2016;29:1286-95. [PMID: 27714853 DOI: 10.1111/tri.12855] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
65 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 34.0] [Reference Citation Analysis]
66 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
67 Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study. Therap Adv Gastroenterol 2022;15:175628482210875. [DOI: 10.1177/17562848221087536] [Reference Citation Analysis]
68 Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther 2020;37:1452-63. [PMID: 32076942 DOI: 10.1007/s12325-020-01250-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
69 Mcmurry H, Sabile JM, Elstrott B, Chobrutskiy B, Mohinani A, Patel S, Gowda S, Martens K, Shatzel J. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Noronha Ferreira C, Reis D, Cortez-Pinto H, Tato Marinho R, Gonçalves A, Palma S, Leite I, Rodrigues T, Pedro AJ, Alexandrino P, Serejo F, Sobral Dias M, Ferreira P, Vasconcelos M, Damião F, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis. Dig Dis Sci 2019;64:2671-83. [PMID: 30852769 DOI: 10.1007/s10620-019-05572-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
71 Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC. Transient portal vein thrombosis in liver cirrhosis. BMC Med 2018;16:83. [PMID: 29871683 DOI: 10.1186/s12916-018-1069-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
72 Riva N, Ageno W. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective. J Transl Int Med 2018;6:6-10. [PMID: 29607297 DOI: 10.2478/jtim-2018-0002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Zhan C, Prabhu V, Kang SK, Li C, Zhu Y, Kim S, Olsen S, Jacobson IM, Dagher NN, Carney B, Hickey RM, Taslakian B. Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment. J Clin Med 2021;10:2316. [PMID: 34073236 DOI: 10.3390/jcm10112316] [Reference Citation Analysis]
74 Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
75 Northup P, Reutemann B. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates. Liver Transpl 2018;24:1119-32. [DOI: 10.1002/lt.25198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
76 Zheng K, Yoshida EM, Tacke F, Li Y, Guo X, Qi X. Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Journal of Clinical Gastroenterology 2020;54:96-105. [DOI: 10.1097/mcg.0000000000001201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
77 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
78 Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F; BO-LIVES (BOlogna LIVEr vascular Studies). Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. Am J Gastroenterol. 2019;114:258-266. [PMID: 30538290 DOI: 10.1038/s41395-018-0421-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 14.7] [Reference Citation Analysis]
79 Zhou T, Sun X, Zhou T, Li Y, Chen X, Cheng B, Gao Y. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial. Clin Transl Gastroenterol 2020;11:e00228. [PMID: 32858573 DOI: 10.14309/ctg.0000000000000228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
80 Riva N, Ageno W, Schulman S, Beyer-westendorf J, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Dentali F. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. The Lancet Haematology 2016;3:e267-75. [DOI: 10.1016/s2352-3026(16)30020-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
81 Mancuso A, Politi F, Maringhini A. Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat? Gastroenterology 2018;154:758. [PMID: 29352958 DOI: 10.1053/j.gastro.2017.07.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
82 Rugivarodom M, Charatcharoenwitthaya P. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. J Clin Transl Hepatol 2020;8:432-44. [PMID: 33447527 DOI: 10.14218/JCTH.2020.00067] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Xu X, Guo X, Wang R, Wang L, Li Q, Yi F, Li H, Qi X. Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures. Ann Hepatol 2020;19:573-7. [PMID: 31521463 DOI: 10.1016/j.aohep.2019.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference. Thromb Haemost. 2018;118:1491-1506. [PMID: 30060258 DOI: 10.1055/s-0038-1666861] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 17.3] [Reference Citation Analysis]